A. Yesil And Y. Yilmaz, "Letter: gut microbiota modulation contributes to coffee's benefits for non-alcoholic fatty liver disease - authors' reply," ALIMENTARY PHARMACOLOGY & THERAPEUTICS , vol.39, no.12, pp.1442, 2014
Yesil, A. And Yilmaz, Y. 2014. Letter: gut microbiota modulation contributes to coffee's benefits for non-alcoholic fatty liver disease - authors' reply. ALIMENTARY PHARMACOLOGY & THERAPEUTICS , vol.39, no.12 , 1442.
Yesil, A., & Yilmaz, Y., (2014). Letter: gut microbiota modulation contributes to coffee's benefits for non-alcoholic fatty liver disease - authors' reply. ALIMENTARY PHARMACOLOGY & THERAPEUTICS , vol.39, no.12, 1442.
Yesil, A., And YUSUF YILMAZ. "Letter: gut microbiota modulation contributes to coffee's benefits for non-alcoholic fatty liver disease - authors' reply," ALIMENTARY PHARMACOLOGY & THERAPEUTICS , vol.39, no.12, 1442, 2014
Yesil, A. And Yilmaz, YUSUF. "Letter: gut microbiota modulation contributes to coffee's benefits for non-alcoholic fatty liver disease - authors' reply." ALIMENTARY PHARMACOLOGY & THERAPEUTICS , vol.39, no.12, pp.1442, 2014
Yesil, A. And Yilmaz, Y. (2014) . "Letter: gut microbiota modulation contributes to coffee's benefits for non-alcoholic fatty liver disease - authors' reply." ALIMENTARY PHARMACOLOGY & THERAPEUTICS , vol.39, no.12, p.1442.
@article{article, author={A. Yesil And author={YUSUF YILMAZ}, title={Letter: gut microbiota modulation contributes to coffee's benefits for non-alcoholic fatty liver disease - authors' reply}, journal={ALIMENTARY PHARMACOLOGY & THERAPEUTICS}, year=2014, pages={1442} }